Medtronic Chairman and CEO Geoff Martha to speak at J.P. Morgan healthcare conference

Rhea-AI Summary

Medtronic plc (NYSE: MDT) has announced its participation in the 40th annual J.P. Morgan healthcare conference, set for January 10, 2022. Chairman and CEO Geoff Martha will present and engage in a Q&A session starting at 8:15 a.m. EST. Investors can access a live webcast of the event via Medtronic's investor relations page. The session will also be archived for later viewing. Medtronic is a prominent healthcare technology company focused on innovative therapies for a range of health conditions, committed to improving global health outcomes.

DUBLIN, Jan. 4, 2022 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced it will participate virtually in the 40th annual J.P. Morgan healthcare conference on Monday, January 10, 2022.

Geoff Martha, Medtronic chairman and chief executive officer, will make a formal presentation and answer questions on the company beginning at 8:15 a.m. EST (7:15 a.m. CST).

A live webcast of the presentation and Q&A session will be available on January 10, 2022, by clicking on the Investor Events link at http://investorrelations.medtronic.com. An archive of the presentation and Q&A session will be available on the same webpage later in the day.

About Medtronic
Bold thinking. Bolder actions. We are Medtronic. Medtronic plc, headquartered in Dublin, Ireland, is the leading global healthcare technology company that boldly attacks the most challenging health problems facing humanity by searching out and finding solutions. Our Mission — to alleviate pain, restore health, and extend life — unites a global team of 90,000+ passionate people across 150 countries. Our technologies and therapies treat 70 health conditions and include cardiac devices, surgical robotics, insulin pumps, surgical tools, patient monitoring systems, and more. Powered by our diverse knowledge, insatiable curiosity, and desire to help all those who need it, we deliver innovative technologies that transform the lives of two people every second, every hour, every day. Expect more from us as we empower insight-driven care, experiences that put people first, and better outcomes for our world. In everything we do, we are engineering the extraordinary. For more information on Medtronic (NYSE:MDT), visit www.Medtronic.com and follow @Medtronic on Twitter and LinkedIn.

Any forward-looking statements are subject to risks and uncertainties such as those described in Medtronic's periodic reports on file with the Securities and Exchange Commission. Actual results may differ materially from anticipated results.

Contacts:
Erika Winkels	Ryan Weispfenning
Public Relations	Investor Relations
+1-763-526-8478	+1-763-505-4626

 

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/medtronic-chairman-and-ceo-geoff-martha-to-speak-at-jp-morgan-healthcare-conference-301453675.html

SOURCE Medtronic plc

FAQ

When is Medtronic's presentation at the J.P. Morgan healthcare conference?

Medtronic will present at the J.P. Morgan healthcare conference on January 10, 2022.

Who will represent Medtronic at the J.P. Morgan healthcare conference?

Chairman and CEO Geoff Martha will represent Medtronic at the conference.

What time is Medtronic's presentation at the conference?

Medtronic's presentation will begin at 8:15 a.m. EST on January 10, 2022.

How can I watch Medtronic's presentation from the J.P. Morgan healthcare conference?

You can watch Medtronic's presentation live by visiting their investor relations webpage on January 10, 2022.

Will there be a recording of Medtronic's presentation available?

Yes, an archive of the presentation will be available on Medtronic's investor relations page later on January 10, 2022.

What is Medtronic's primary focus as a healthcare company?

Medtronic focuses on innovative therapies to treat a variety of health conditions and improve patient outcomes.